393 related articles for article (PubMed ID: 25774345)
1. microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts.
Schulte C; Zeller T
Cardiovasc Diagn Ther; 2015 Feb; 5(1):17-36. PubMed ID: 25774345
[TBL] [Abstract][Full Text] [Related]
2. miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease.
Schulte C; Molz S; Appelbaum S; Karakas M; Ojeda F; Lau DM; Hartmann T; Lackner KJ; Westermann D; Schnabel RB; Blankenberg S; Zeller T
PLoS One; 2015; 10(12):e0145930. PubMed ID: 26720041
[TBL] [Abstract][Full Text] [Related]
3. microRNAs in cardiovascular disease - clinical application.
Schulte C; Karakas M; Zeller T
Clin Chem Lab Med; 2017 May; 55(5):687-704. PubMed ID: 27914211
[TBL] [Abstract][Full Text] [Related]
4. Role of Selected miRNAs as Diagnostic and Prognostic Biomarkers in Cardiovascular Diseases, Including Coronary Artery Disease, Myocardial Infarction and Atherosclerosis.
Mir R; Elfaki I; Khullar N; Waza AA; Jha C; Mir MM; Nisa S; Mohammad B; Mir TA; Maqbool M; Barnawi J; Albalawi SO; Abu-Duhier FM
J Cardiovasc Dev Dis; 2021 Feb; 8(2):. PubMed ID: 33669699
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs as Potential Biomarkers in Coronary Artery Disease.
Bergami M; Fabin N; Cenko E; Bugiardini R; Manfrini O
Curr Top Med Chem; 2023; 23(6):454-469. PubMed ID: 36545717
[TBL] [Abstract][Full Text] [Related]
6. Next generation MicroRNA sequencing to identify coronary artery disease patients at risk of recurrent myocardial infarction.
Kanuri SH; Ipe J; Kassab K; Gao H; Liu Y; Skaar TC; Kreutz RP
Atherosclerosis; 2018 Nov; 278():232-239. PubMed ID: 30336307
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fraction.
Schulte C; Westermann D; Blankenberg S; Zeller T
World J Cardiol; 2015 Dec; 7(12):843-60. PubMed ID: 26730290
[TBL] [Abstract][Full Text] [Related]
8. Circulating miRNAs as biomarkers for early diagnosis of coronary artery disease.
Zhang L; Zhang Y; Zhao Y; Wang Y; Ding H; Xue S; Li P
Expert Opin Ther Pat; 2018 Aug; 28(8):591-601. PubMed ID: 30064285
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic and prognostic value of circulating microRNAs in coronary artery disease: A novel approach to disease diagnosis of stable CAD and acute coronary syndrome.
Parizadeh SM; Ferns GA; Ghandehari M; Hassanian SM; Ghayour-Mobarhan M; Parizadeh SMR; Avan A
J Cell Physiol; 2018 Sep; 233(9):6418-6424. PubMed ID: 29215707
[TBL] [Abstract][Full Text] [Related]
10. Assessment of microRNAs in patients with unstable angina pectoris.
Zeller T; Keller T; Ojeda F; Reichlin T; Twerenbold R; Tzikas S; Wild PS; Reiter M; Czyz E; Lackner KJ; Munzel T; Mueller C; Blankenberg S
Eur Heart J; 2014 Aug; 35(31):2106-14. PubMed ID: 24727883
[TBL] [Abstract][Full Text] [Related]
11. MiR-486 and miR-92a Identified in Circulating HDL Discriminate between Stable and Vulnerable Coronary Artery Disease Patients.
Niculescu LS; Simionescu N; Sanda GM; Carnuta MG; Stancu CS; Popescu AC; Popescu MR; Vlad A; Dimulescu DR; Simionescu M; Sima AV
PLoS One; 2015; 10(10):e0140958. PubMed ID: 26485305
[TBL] [Abstract][Full Text] [Related]
12. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.
Zhou SS; Jin JP; Wang JQ; Zhang ZG; Freedman JH; Zheng Y; Cai L
Acta Pharmacol Sin; 2018 Jul; 39(7):1073-1084. PubMed ID: 29877320
[TBL] [Abstract][Full Text] [Related]
13. miRNA-93-5p and other miRNAs as predictors of coronary artery disease and STEMI.
O Sullivan JF; Neylon A; McGorrian C; Blake GJ
Int J Cardiol; 2016 Dec; 224():310-316. PubMed ID: 27665403
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs and Cardiovascular Disease Risk.
Searles CD
Curr Cardiol Rep; 2024 Feb; 26(2):51-60. PubMed ID: 38206553
[TBL] [Abstract][Full Text] [Related]
15. Prospective and therapeutic screening value of non-coding RNA as biomarkers in cardiovascular disease.
Busch A; Eken SM; Maegdefessel L
Ann Transl Med; 2016 Jun; 4(12):236. PubMed ID: 27429962
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNAs in suspected stable coronary artery disease: A coronary computed tomography angiography study.
de Gonzalo-Calvo D; Vilades D; Martínez-Camblor P; Vea À; Nasarre L; Sanchez Vega J; Leta R; Carreras F; Llorente-Cortés V
J Intern Med; 2019 Sep; 286(3):341-355. PubMed ID: 31141242
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs as circulating biomarkers in acute coronary syndromes: A review.
Ahlin F; Arfvidsson J; Vargas KG; Stojkovic S; Huber K; Wojta J
Vascul Pharmacol; 2016 Jun; 81():15-21. PubMed ID: 27084396
[TBL] [Abstract][Full Text] [Related]
18. MiR-423 is differentially expressed in patients with stable and unstable coronary artery disease: A pilot study.
Rizzacasa B; Morini E; Mango R; Vancheri C; Budassi S; Massaro G; Maletta S; Macrini M; D'Annibale S; Romeo F; Novelli G; Amati F
PLoS One; 2019; 14(5):e0216363. PubMed ID: 31059534
[TBL] [Abstract][Full Text] [Related]
19. Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndrome.
Kwee LC; Neely ML; Grass E; Gregory SG; Roe MT; Ohman EM; Fox KAA; White HD; Armstrong PW; Bowsman LM; Haas JV; Duffin KL; Chan MY; Shah SH
Physiol Genomics; 2019 Oct; 51(10):506-515. PubMed ID: 31530226
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms offer insight into the causal role of microRNA in coronary artery disease.
Borghini A; Andreassi MG
Atherosclerosis; 2018 Feb; 269():63-70. PubMed ID: 29276984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
